Arkolith/Insider Trading/TERN/Form 4

Tripuraneni Radhika

DirectorTerns Pharmaceuticals, Inc. (TERN) · full profile →Form 4 · filed May 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Disposed to issuer(D)64K——0
May 5, 2026Disposed to issuer(D)45K——0
May 5, 2026Disposed to issuer(D)11K——0
May 5, 2026Disposed to issuer(D)5K——0
May 5, 2026Disposed to issuer(D)32K——0
May 5, 2026Disposed to issuer(D)32K——0
May 5, 2026Disposed to issuer(D)2K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001761114-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML